Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - AILERON THERAPEUTICS INC | alrn-ex322_7.htm |
| EX-32.1 - EX-32.1 - AILERON THERAPEUTICS INC | alrn-ex321_6.htm |
| EX-31.2 - EX-31.2 - AILERON THERAPEUTICS INC | alrn-ex312_8.htm |
| EX-31.1 - EX-31.1 - AILERON THERAPEUTICS INC | alrn-ex311_9.htm |
| 10-K - 10-K - AILERON THERAPEUTICS INC | alrn-10k_20171231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-219158) of Aileron Therapeutics, Inc. of our report dated March 29, 2018 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
April 2, 2018